DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
Wordsworth
Sarah
S
Health Economics Research Centre, University of Oxford, Old Road Campus, Oxford OX3 7LF, UK. sarah.wordsworth@dphpc.ox.ac.uk
Leal
José
J
Blair
Edward
E
Legood
Rosa
R
Thomson
Kate
K
Seller
Anneke
A
Taylor
Jenny
J
Watkins
Hugh
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D024741:Cardiomyopathy, Hypertrophic, Familial / Q000175:diagnosis* / Q000191:economics / Q000235:genetics; D002648:Child; D003362:Cost-Benefit Analysis; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D003663:Decision Trees; D005544:Forecasting; D005820:Genetic Testing / Q000191:economics* / Q000592:standards; D006801:Humans; D008875:Middle Aged; D018803:Models, Economic; D010375:Pedigree; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D055815:Young Adult